We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

116 hedge funds and large institutions have $1.36B invested in IVERIC bio, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 42 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 9

83% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 23

26% more funds holding

Funds holding: 92 → 116 (+24)

20% more capital invested

Capital invested by funds: $1.13B → $1.36B (+$228M)

14% less funds holding in top 10

Funds holding in top 10: 7 → 6 (-1)

40% less call options, than puts

Call options by funds: $2.92M | Put options by funds: $4.84M

Holders
116
Holders Change
+24
Holders Change %
+26.09%
% of All Funds
3.09%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.16%
New
34
Increased
42
Reduced
23
Closed
9
Calls
$2.92M
Puts
$4.84M
Net Calls
-$1.92M
Net Calls Change
-$1.24M

Top Buyers

1
O
OrbiMed
New York
+$22M
2
BFA
BlackRock Fund Advisors
California
+$18.7M
3
Morgan Stanley
Morgan Stanley
New York
+$15.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.3M
5
JCG
JHL Capital Group
Illinois
+$8.19M

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
-$41.8M
2
SHI
SV Health Investors
Massachusetts
-$28.9M
3
RCM
RA Capital Management
Massachusetts
-$11.7M
4
GPP
Great Point Partners
Connecticut
-$11.7M
5
PA
Perceptive Advisors
New York
-$3.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$1.37M +$179K +4,258 +16%
Charles Schwab
52
Charles Schwab
California
$1.36M +$28.2K +671 +2%
WHI
53
William Harris Investors
Illinois
$1.35M -$84K -2,000 -6%
SGAM
54
Smith Group Asset Management
Texas
$1.29M -$113K -2,700 -9%
Federated Hermes
55
Federated Hermes
Pennsylvania
$1.29M +$661K +15,738 +121%
Ameriprise
56
Ameriprise
Minnesota
$1.17M -$211K -5,016 -16%
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1.16M +$4.58K +109 +0.4%
ProShare Advisors
58
ProShare Advisors
Maryland
$1.13M +$829K +19,747 +358%
AI
59
Analytic Investors
California
$1.11M +$720K +17,155 +224%
TD Asset Management
60
TD Asset Management
Ontario, Canada
$1.11M +$29.4K +700 +3%
AL
61
Airain Ltd
Guernsey
$1.01M +$431K +10,264 +84%
RJA
62
Raymond James & Associates
Florida
$995K +$175K +4,172 +23%
OC
63
Oppenheimer & Co
New York
$926K +$100K +2,387 +13%
RFC
64
Russell Frank Company
Washington
$902K -$222K -5,284 -21%
GF
65
Gabelli Funds
New York
$897K – – –
TA
66
Teachers Advisors
New York
$863K – – –
SIM
67
Spark Investment Management
New York
$847K +$794K +18,900 New
ARTA
68
A.R.T. Advisors
New York
$827K +$775K +18,444 New
AQR Capital Management
69
AQR Capital Management
Connecticut
$790K +$739K +17,600 New
State of New Jersey Common Pension Fund D
70
State of New Jersey Common Pension Fund D
New Jersey
$785K – – –
Deutsche Bank
71
Deutsche Bank
Germany
$781K -$514K -12,244 -41%
SKK
72
Shepherd Kaplan Krochuk
Massachusetts
$751K – – –
Renaissance Technologies
73
Renaissance Technologies
New York
$731K +$685K +16,300 New
Jacobs Levy Equity Management
74
Jacobs Levy Equity Management
New Jersey
$699K +$654K +15,580 New
Swiss National Bank
75
Swiss National Bank
Switzerland
$691K – – –
1 2
3
4 5

ISEE Hedge Fund Activity: Q4 2014 in Review

116 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2014, worth a combined $1.36B — up 20% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ISEE positions and 9 closed out — a net gain of 25 holders — while 42 added to existing stakes and 23 trimmed.

The largest buyer was OrbiMed, adding an estimated $22M. The largest seller was Novo Holdings A/S, cutting an estimated $41.8M.

  • 116 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2014, up from 92 in Q3 2014.
  • Funds reported $1.36B of IVERIC bio, Inc. Common Stock stock for Q4 2014, up 20% quarter-over-quarter.
  • 34 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2014 and 9 closed out, a net change of +25 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q4 2014 was OrbiMed, an estimated $22M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q4 2014 was Novo Holdings A/S, an estimated $41.8M sold.

Based on aggregated 13F filings for Q4 2014.